HRT Financial’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-80,224	Closed	-$93K	–	2760
2024 Q2	$93K	Buy	+80,224	New	+$93K	﹤0.01%	1598
2023 Q2	–	Sell	-10,309	Closed	-$21K	–	2877
2023 Q1	$21K	Buy	+10,309	New	+$21K	﹤0.01%	1997